YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Regeneron to buy 23andMe for $256M

Posted online

Drugmaker Regeneron Pharmaceuticals is set to buy genetic testing firm 23andMe through bankruptcy proceedings.

The deal is valued at $256 million.

23andMe has collected genetic data from some 15 million customers.

Read more from Reuters.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences